Impel Pharmaceuticals Inc (IMPL) Annual Balance Sheets

Annual · GAAP · USD millions
Access IMPL quarterly Balance Sheets →
A period-by-period view of the balance sheet from Impel Pharmaceuticals Inc to helps clarify how Dec 31 2022's financial structure has changed over time.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2022)
(Dec 31 2021)
Assets
Cash & cash equivalent60.65
Cash & Short-term Investments60.00
Accounts receivable7.44
Inventories8.43
Prepaid Expense And Other Assets Current3.28
Total Current Assets79.81
Equipment/Property/Plant Net3.86
Other Assets, Noncurrent3.00
Operating Lease Right Of Use Asset3.13
Total Assets88.55
Liabilities
Accounts Payable, Current AC6.09
Accrued Liabilities And Other Liabilities12.24
Other Liabilities, Current3.83
Total Current Liabilities22.16
Long-term debt48.07
Total Long-term Debt48.07
Other liabilities, Noncurrent62.47
Deferred Royalty Obligation Current2.03
Operating Lease Liability Current1.54
Common Stock Warrant Liabilities0.26
Operating Lease Liability Noncurrent1.57
Deferred Royalty Obligation Non Current60.90
Total Liabilities132.71
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock276.93
Retained Earnings / Accumulated Deficit-321.11
Other Equity0.00
Common Stockholder's Equity-44.16
Total Stockholder's Equity-44.16
Liabilities & Stockholder's Equity88.55
4 historic quarters locked

Sign in to unlock the full Impel Pharmaceuticals Inc balance sheet history.

About Impel Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-23-063759

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.